
Baxter International Inc. (NYSE: BAX) stands prominently within the healthcare sector, particularly in the medical instruments and supplies industry. With a market capitalization of $12.68 billion, Baxter’s extensive portfolio caters..
Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, is currently positioned at a pivotal moment for investors seeking opportunities in medical instruments and supplies. With a market..
Baxter International Inc. (NYSE: BAX) stands as a significant player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $12.42 billion, this Deerfield, Illinois-based..
Baxter International Inc. (NYSE: BAX) remains a focal point for investors seeking opportunities within the healthcare sector, particularly in the medical instruments and supplies industry. With a market capitalization of..
Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, is currently navigating a complex landscape characterized by both challenges and opportunities. With a market capitalization of $11.27 billion,..
Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, presents an intriguing opportunity for investors despite facing some notable challenges. With a market capitalization of $14.99 billion,..
Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, stands at an intriguing juncture for investors. With a market capitalization of $14.25 billion, the company is a prominent..
Baxter International Inc. (NYSE: BAX), a notable player in the healthcare sector, continues to capture investor attention with a compelling opportunity for upside. As the company navigates a complex landscape..
Baxter International Inc. (NYSE: BAX), a staple in the healthcare sector, is garnering increased attention from investors due to its expansive portfolio and a potential upside of 23.65%, as suggested..
Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, presents an intriguing opportunity for investors with its substantial potential upside. The company’s diverse portfolio of medical instruments and..
Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, offers investors a unique opportunity to delve into the medical instruments and supplies industry. With a market capitalization of..
Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, is navigating choppy waters with its diverse portfolio of medical instruments and supplies. Headquartered in Deerfield, Illinois, Baxter operates..
Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, presents intriguing opportunities for investors navigating the medical instruments and supplies industry. With a market capitalization of $15.53 billion,..
Investors eyeing opportunities in the healthcare sector may find Baxter International Inc. (NYSE: BAX) an intriguing option. With a market capitalization of $15.65 billion, this American stalwart in the medical..
Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, continues to captivate investor interest with its diverse portfolio of medical products and therapies. Despite some recent financial hurdles,..
Baxter International Inc. with ticker code (BAX) now have 11 analysts in total covering the stock. The consensus rating is pointing to ‘hold’. The target price High/Low ranges between $46.00..
Baxter International Inc. with ticker code (BAX) have now 13 analysts in total covering the stock. The consensus rating is pointing to ‘hold’. The target price High/Low ranges between $54.00..
Baxter International Inc. with ticker code (BAX) now have 13 analysts in total covering the stock. The consensus rating is pointing to ‘hold’. The target price High/Low ranges between $54.00..
Baxter International Inc. which can be found using ticker (BAX) have now 13 analysts in total covering the stock. The consensus rating is pointing to ‘hold’. The target price High/Low..
Baxter International Inc. which can be found using ticker (BAX) now have 13 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The target price High/Low..